Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Actn4em1flox/Cya
Common Name:
Actn4-flox
Product ID:
S-CKO-12554
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Actn4-flox
Strain ID
CKOCMP-60595-Actn4-B6J-VA
Gene Name
Actn4
Product ID
S-CKO-12554
Gene Alias
-
Background
C57BL/6JCya
NCBI ID
60595
Modification
Conditional knockout
Chromosome
7
Phenotype
MGI:1890773
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Actn4em1flox/Cya mice (Catalog S-CKO-12554) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000068045
NCBI RefSeq
NM_021895
Target Region
Exon 4~6
Size of Effective Region
~3.6 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Actn4, an actin-binding protein, belongs to the family of non-muscle alpha-actinin. It is crucial for multiple cytoplasmic and nuclear processes, such as cytoskeleton reorganization and regulation of signaling pathways [1]. Actn4 has been associated with various biological functions and disease-related pathways, including cancer development, viral infection, and kidney function regulation. Genetic models, like KO or CKO mouse models, can be valuable in further exploring its functions.

In cancer research, Actn4 has been linked to tumorigenesis, metastasis, and epithelial-mesenchymal transition (EMT). In thymic epithelial tumors, overexpression of Actn4 enhanced cell proliferation and invasion, while knockdown suppressed these malignant potential characteristics through the β-catenin/Slug pathway [5]. In hepatocellular carcinoma, the CCT3/Actn4/TFRC axis protects cells from ferroptosis by inhibiting iron endocytosis, and targeting this axis may overcome sorafenib resistance [3]. In intrahepatic cholangiocarcinoma, circular RNA circActn4, originating from the Actn4 gene, promotes tumor progression by acting as a molecular sponge of miR-424-5p and interacting with YBX1 to transcriptionally activate FZD7 [2]. In melanoma, Actn4 stabilizes receptor-interacting protein kinase 1 (RIPK1), forming an oncogenic feed-forward signaling axis of Actn4-RIPK1-NF-κB, and silencing Actn4 suppresses melanoma cell proliferation [8].

In other fields, Actn4 is involved in sperm head formation, as SEPT14 mutations disrupt Actn4 functions and lead to sperm head defects [7]. In kidney podocytes, phosphorylation of Actn4 at serine 159 affects its binding to F-actin, leading to podocyte detachment and proteinuric glomerulosclerosis [6]. Additionally, Actn4 has been characterized as a novel antiviral target against SARS-CoV-2, with its agonists YS-49 and demethyl-coclaurine inhibiting viral infection [4].

In conclusion, Actn4 is essential for a wide range of biological processes. Through model-based research, it has been shown to play significant roles in cancer, sperm development, kidney function, and viral infection. The use of KO/CKO mouse models could potentially further clarify its functions in these specific disease areas and biological processes.

References:
1. Tentler, Dmitri, Lomert, Ekaterina, Novitskaya, Ksenia, Barlev, Nikolai A. 2019. Role of ACTN4 in Tumorigenesis, Metastasis, and EMT. In Cells, 8, . doi:10.3390/cells8111427. https://pubmed.ncbi.nlm.nih.gov/31766144/
2. Chen, Qinjunjie, Wang, Haibo, Li, Zheng, Wang, Kui, Shen, Feng. 2021. Circular RNA ACTN4 promotes intrahepatic cholangiocarcinoma progression by recruiting YBX1 to initiate FZD7 transcription. In Journal of hepatology, 76, 135-147. doi:10.1016/j.jhep.2021.08.027. https://pubmed.ncbi.nlm.nih.gov/34509526/
3. Zhu, Huihui, Liu, Qiuhong, Meng, Qinna, Li, Lanjuan, Ji, Feiyang. 2024. CCT3/ACTN4/TFRC axis protects hepatocellular carcinoma cells from ferroptosis by inhibiting iron endocytosis. In Journal of experimental & clinical cancer research : CR, 43, 245. doi:10.1186/s13046-024-03169-7. https://pubmed.ncbi.nlm.nih.gov/39210442/
4. Zhu, Miao, Huang, Fang, Sun, Huize, Shan, Chao, Guan, Wuxiang. 2024. Characterization of ACTN4 as a novel antiviral target against SARS-CoV-2. In Signal transduction and targeted therapy, 9, 243. doi:10.1038/s41392-024-01956-4. https://pubmed.ncbi.nlm.nih.gov/39289355/
5. Nagata, Hideki, Funaki, Soichiro, Kimura, Kenji, Morii, Eiichi, Shintani, Yasushi. 2024. ACTN4 is associated with the malignant potential of thymic epithelial tumors through the β-catenin/Slug pathway. In Cancer science, 115, 3636-3647. doi:10.1111/cas.16313. https://pubmed.ncbi.nlm.nih.gov/39166351/
6. Feng, Di, Kumar, Mukesh, Muntel, Jan, Steen, Hanno, Pollak, Martin R. 2020. Phosphorylation of ACTN4 Leads to Podocyte Vulnerability and Proteinuric Glomerulosclerosis. In Journal of the American Society of Nephrology : JASN, 31, 1479-1495. doi:10.1681/ASN.2019101032. https://pubmed.ncbi.nlm.nih.gov/32540856/
7. Lin, Yu-Hua, Huang, Chia-Yen, Ke, Chih-Chun, Chan, Chying-Chyuan, Lin, Ying-Hung. 2020. ACTN4 Mediates SEPT14 Mutation-Induced Sperm Head Defects. In Biomedicines, 8, . doi:10.3390/biomedicines8110518. https://pubmed.ncbi.nlm.nih.gov/33228246/
8. Zhang, Yuan Yuan, Tabataba, Hessam, Liu, Xiao Ying, Zhang, Xu Dong, Jin, Lei. 2018. ACTN4 regulates the stability of RIPK1 in melanoma. In Oncogene, 37, 4033-4045. doi:10.1038/s41388-018-0260-x. https://pubmed.ncbi.nlm.nih.gov/29706658/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest